Curriculum vitae - Faculty of Pharmacy

advertisement
Curriculum Vitae
1. Personal Details:
Name:
Mina Ibrahim Tadros Ayad.
Occupation: Ass. Professor, Pharmaceutics and Industrial Pharmacy,
Faculty of Pharmacy, Cairo University, Egypt.
Nationality: Egyptian.
Home Address: 26 Adnan Elmadany St., Elmohandessin, Giza, Egypt.
Home Tel
+20-2-33458719.
Mobile Tel.
+20-122-3620458.
Date of Birth: 23 / 12 / 1975.
Marital status: married with 2 kids.
E-mail:
mina_ebrahim@yahoo.com.
2. Academic Degrees:
1. Ph.D., Faculty of Pharmacy, Cairo university, 9 / 5 / 2006.
Title of thesis: “Optimization of certain inhaler formulations of an anti-asthmatic drug”.
Under the supervision of: Prof. Dr. Ahmed Abd-Elbary Abd-Elrahman
Prof. Dr. Hanan Mohamed El-laithy
2. M.Sc., Faculty of Pharmacy, Cairo university, 24 / 11 / 2002.
Title of thesis: “A study of certain polymers as controlled release drug carrier systems”.
Under the supervision of: Prof. Dr. Nagwa Hussein Foda
Prof. Dr. Hanan Mohamed El-laithy
3. B.Sc., Faculty of Pharmacy, Cairo university, May 1998.
Graduation degree: Excellent with honors.
3. Career History:
1. Associate Professor, Department of Pharmaceutics and Industrial Pharmacy, Faculty
of Pharmacy, Cairo University, from 28/03/2012 till now.
2. Lecturer, Department of Pharmaceutics and Industrial Pharmacy, Faculty of
Pharmacy, Cairo University, from 04/06/2006 till 27/03/2012.
3. Assistant Lecturer, Department of Pharmaceutics and Industrial Pharmacy, Faculty
of Pharmacy, Cairo University, from 05/01/2003 till 03/06/2006.
4. Teaching Assistant, Department of Pharmaceutics and Industrial Pharmacy, Faculty
of Pharmacy, Cairo University, from 21/10/1998 till 04/01/2003.
4. Teaching Activities:
1. In the Dept. of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy,
Cairo University.
1.1. Under-graduate courses:
Participated in the delivery of the following courses;
-1-
1. Community Pharmacy, Theoretical and practical course for 4th year students (Old
system), 2006 / 2007.
2. Industrial Pharmacy, Theoretical and practical course for 4th year students (Old
system), 2006 / 2007.
3. Pharmaceutical Technology I (112), Theoretical and practical course for 5th year
students (New system), 2007 / 2008 till 2009 / 2010.
4. Pharmaceutical Technology II (113), Theoretical and practical course for 5th year
students (New system), 2007 / 2008 till now.
1. 2. Post-graduate courses:
Participated in the delivery of the following courses;
1. Transdermal drug delivery system, Theoretical course for Diploma of Industrial
Pharmacy graduates (Old system), from 2006 / 2007 till 2008 / 2009.
2. Solid dosage forms, practical course for Diploma of Industrial Pharmacy graduates
(Old system), from 2006 / 2007 till 2008 / 2009.
3. Mechanical utilities and services (2111), Theoretical course for Master of Industrial
Pharmacy graduates (New system), from 2009 / 2010 till now.
4. Mechanical utilities and services (2111), Theoretical course for Diploma of
Industrial Pharmacy graduates (New system), from 2009 / 2010 till now.
2. In the Dept. of Analytical Chemistry, Faculty of Pharmacy, Cairo University.
1. Validation, GMP, ISO and quality assurance (2109), Theoretical course for Diploma
of Analytical chemistry graduates (New system), from 2009 / 2010 till now.
3. In the Dept. of Pharmaceutical Technology, Faculty of Pharmacy, Misr
International University
1. Hospital pharmacy I (PHP 421), Theoretical and practical course for 4th year
students, 2006 / 2007 (Fall semester).
2. Reaction Kinetics (PHT 421), Theoretical and practical course for 4th year students,
2006 / 2007 (Fall semester).
3. Pharmaceutics I (PHP 213), Theoretical and practical course for 2nd year students,
2006 / 2007 (Spring semester).
4. Physical pharmacy (PHT 212), Theoretical and practical course for 2nd year students,
2007 / 2008 (Fall semester).
4. In the Dept. of Pharmaceutical Technology, Faculty of Pharmacy, Future
University
1. Orientation and History of Pharmacy (PHT 101), Theoretical and practical course for
1st year students, 2007 / 2008 (Spring semester).
2. Pharmacy and Medical Terminology (PHL 102), Theoretical course for 2nd year
students, 2007 / 2008 (Spring semester).
3. Introduction to Pharmaceutics (PHT 212), Theoretical and practical course for 2nd
year students, from 2008 / 2009 till 2009 / 2010 (Fall semester).
4. Pharmaceutics II (PHT 213), Theoretical and practical course for 3rd year students,
from 2008 / 2009 till 2009 / 2010 (Fall semester).
-2-
5. Pharmaceutics III (PHT 314), Theoretical and practical course for 3rd year students,
from 2008 / 2009 till 2009 / 2010 (Spring semester).
6. Industrial Pharmacy I (PHP 522), Theoretical and practical course for 5th year
students, from 2010 / 2011 till now.
7. Industrial Pharmacy II (PHP 523), Theoretical and practical course for 5th year
students, from 2010 / 2011 till now.
8. Quality control and quality assurance (PHP 531), Theoretical and practical course
for 5th year students, from 2010 / 2011 till now.
5. Academic supervision on Ph.D. and Master Thesis:
Supervisor on two Ph.D. thesis and five master thesis on Pharmaceutical Sciences
(Pharmaceutics) registered in the Faculty of Pharmacy, Cairo University.
6. Training Programs:
1. Meetings and managing time, Faculty and leadership development center (FLDC),
Cairo University, Egypt, December 8 – 10, 2012.
2. Communication skills, Faculty and leadership development center (FLDC), Cairo
University, Egypt, July 14 – 16, 2012.
3. Code of Ethics, Faculty and leadership development center (FLDC), Cairo
University, Egypt, February 22 – 24, 2010.
4. Recent trends in teaching, Faculty and leadership development center (FLDC),
Cairo University, Egypt, July 27 – 29, 2009.
5. Effective presentation, Faculty and leadership development center (FLDC), Cairo
University, Egypt, September 15 – 17, 2008.
6. Scientific research and international publishing, Faculty and leadership
development center (FLDC), Cairo University, Egypt, February 5 – 7, 2007.
7. Planning a scientific Syllabus, Faculty and leadership development center (FLDC),
Cairo University, Egypt, January 29 – 31, 2007.
8. Preparation of a research project, Faculty and leadership development center
(FLDC), Cairo University, Egypt, January 22 – 24, 2007.
7. Workshops:
1. FUE international workshop on modern tablet manufacturing, QC/QA and
bioavailability/bioequivalence,
Faculty of
Pharmaceutical
sciences
and
pharmaceutical manufacturing, Future University, Egypt, February 20 – 21, 2013.
2. Quality by design (QbD), a new concept of FDA, Faculty of Pharmacy, Cairo
University, Egypt, September 9, 2012.
3. Managements of risks, crisis and evacuation plan, Faculty of Pharmacy, Cairo
University, Egypt, April 15, 2010.
4. Electronic learning concept, Faculty of Pharmacy, Cairo University, Egypt,
December 30, 2008.
-3-
5. New Trends in Tablet Coating, organized by Colorcon Excipients Company,
Center of Applied Research and Advanced Studies, Faculty of Pharmacy, Cairo
University, Egypt, February11, 2008.
6. Recent advances in Clinical Pharmacy and Biotechnology, Faculty of Pharmacy,
Cairo University, Egypt, November 26, 2007.
7. Stability Testing to Support Pharmaceutical Industry in Egypt, Center of
Applied Research and Advanced Studies, Faculty of Pharmacy, Cairo University,
Egypt, October 22, 2007.
8. Updates in cosmeceutical Era, Faculty of Pharmacy, Cairo University, Egypt, April
30, 2007.
9. Optimizing pharmaceutical care and future roles of pharmacists, Misr
International University, Cairo, Egypt, February 12, 2007.
Attested by: Joseph DiPiro, Professor and executive dean, South Carolina College of
Pharmacy, Medical University of South Carolina, USA.
10. New drug updates and adverse drug reactions reporting, Misr International
University, Cairo, Egypt, October 24, 2006.
Attested by: J. Russell May, Clinical Professor, Department of clinical and
administrative pharmacy, College of Pharmacy, University of Georgia, USA.
8. Patent-ownership:
Participated in the following patents;
1. Patent no. 24388, awarded by The Academy of scientific research and technology,
Egyptian Patent office, Egypt, 04/04/2006.
Elbary AA, El-laithy HM, Tadros MI, A method for the preparation of nebulizable
micronized niosomes of cromolyn sodium using non ionic surfactants.
2. Patent no. 23170, awarded by The Academy of scientific research and technology,
Egyptian Patent office, Egypt, 25/09/2002.
Foda NH, El-laithy HM, Tadros MI. A method for the production of biodegradable
chitosan - gelatin sponges containing tramadol hydrochloride.
9. Faculty of Pharmacy, Cairo University-related activities:
1. A member of the committee responsible for organization and regulation of the
student’s union elections in the Faculty of Pharmacy, Cairo University.
2. A supervisor on many student-trips to industrial firms.
3. A member of the academic standards and educational programs committee.
4. A member of the course coordinators committee for post graduate studies.
5. A member of the committee responsible for organization and development of the
research plan (2009 – 2013) of the department of Pharmaceutics and industrial
Pharmacy, Faculty of Pharmacy, Cairo University.
6. A member of the committee responsible for setting the post-graduate programme
specifications offered by the department of Pharmaceutics and industrial Pharmacy,
Faculty of Pharmacy, Cairo University, including;
-4-
Ph.D. of Pharmaceutics, Ph.D. of Industrial Pharmacy, Master of Pharmaceutics,
Master of Industrial Pharmacy, Diploma of Hospital Pharmacy, Diploma of Cosmetics
and Diploma of Industrial Pharmacy.
7. A member of the committee responsible for setting the under-graduate courses of
Industrial Pharmacy I (112) and Industrial Pharmacy II (113).
8. A member of the committee responsible for the inventory of chemical store for the
department of Pharmaceutics and industrial Pharmacy, Faculty of Pharmacy, Cairo
University from 2006 / 2007 till 2009 / 2010.
9. Head of the committee responsible for evaluation of the provided chemicals and
glassware to the department of Pharmaceutics and industrial Pharmacy, Faculty of
Pharmacy, Cairo University from 2010 / 2011 till now.
10. Peer reviewer in the following international journals:
1. European journal of pharmaceutics and biopharmaceutics.
2. International journal of pharmaceutics.
3. Expert opinion on drug delivery.
4. Journal of pharmacy and pharmacology.
5. Journal of biomacromolecules.
6. AAPS PharmSciTech.
7. Drug delivery.
8. Drug development and industrial pharmacy.
9. Pharmaceutical development and technology.
10. Asian journal of pharmaceutics.
11. Scientific conferences:
I. Participation by attendance:
1. FUE international conference on pharmaceutical technologies, Cairo, Egypt,
February 6 – 9, 2012.
2. 5th international conference of scientific research and its applications, Cairo
University, Cairo, Egypt, December 21 – 24, 2009.
3. 30th International Pharmaceutical Sciences Conference, Cairo, Egypt, December
19 – 21, 2006.
II. Participation by presenting research-posters:
1. 2012 AAPS annual meeting and exposition, Chicago, IL, USA, October 14 – 18,
2012.
Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Development and in
vitro/in vivo evaluation of positively charged ocular nanoparticles of an antifungal
drug.
2. 3rd international conference of Faculty of Pharmacy, Cairo University, Cairo,
Egypt, April 25 – 26, 2012.
-5-
Abd-Elbary A, Tadros MI, Alaa-Eldin AA. Preparation and in vitro/in vivo evaluation
of etodolac lipid matrix tablets.
3. 12th European symposium on controlled drug delivery, University of Twente,
Egmond aan Zee, The Netherlands, April 4 – 6, 2012.
Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Ion-sensitive, in situ ocular
nanoemulsion gels of terbinafine hydrochloride: Development and evaluation.
4. 13th AARU conference of the Pan Arab Colleges of Pharmacy, Misr University
for Science and Technology, Cairo, Egypt, May 25 – 27, 2010.
Abd-Elbary A, Tadros MI, Alaa-Eldin AA. Comparative pharmacokinetics of etodolac
in healthy human volunteers following oral administration of engineered controlled
porosity osmotic pump tablets and immediate release market capsules.
5. 7th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical
technology, Mediterranean Conference center, Valetta, Malta, March 8 – 11, 2010.
Abd-Elbary A, Tadros MI, Alaa-Eldin AA. Development of controlled porosity osmotic
pump tablets of etodolac.
6. 1st Scientific Conference of Faculty of Pharmacy, Cairo University, Egypt,
March 29, 2008.
Abdelbary GA, Tadros MI. Design and in vitro/in vivo evaluation of novel nicorandil
extended release matrix tablets based on hydrophilic interpolymer complexes and a
hydrophobic waxy polymer.
7. 3rd International conference of pharmaceutical and drug industries division,
National Research Center, Cairo, Egypt, 6th – 8th March, 2007.
Bendas ER, Tadros MI. Transdermal delivery of salbutamol sulfate via ethosomes.
8. 65th annual International Pharmaceutical Federation (FIP) Conference, Cairo,
Egypt, 2nd – 8th September, 2005.
Elbary AA, El-laithy HM, Tadros MI. Promising alternative carriers to lactose
monohydrate for cromolyn sodium dry powder inhalation.
9. 12th International Pharmaceutical Technology Symposium, Istanbul, Turkey, 12th
– 15th September, 2004, Presented by Prof.Dr. Hanan M. El-laithy.
Foda NH, El-laithy HM, Tadros MI. Implantable Biodegradable Sponges: Effect of
inter-polymer complex formation of chitosan with gelatin on the release behavior of
tramadol hydrochloride.
10. 28th Conference of Pharmaceutical Sciences, The Pharmaceutical Society of
Egypt, Cairo, Egypt, 17th – 19th December, 2002, Presented by Prof.Dr. Hanan M. Ellaithy.
Foda NH, El-laithy HM, Tadros MI. Chitosan sponges as controlled release drug
carrier systems.
12. Publications:
1. Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. Promising ion-sensitive
in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro
-6-
characterization and in vivo estimation of the ocular irritation and drug
pharmacokinetics in the aqueous humor of rabbits. Int J Pharm. 2013, 443: 293– 305.
2. Abd-Elbary A, Tadros MI, Alaa-Eldin AA. Sucrose stearate-enriched lipid matrix
tablets of etodolac: modulation of drug release, diffusional modeling and structure
elucidation studies. AAPS PharmSciTech 2013. Under press.
3. Ghorab DM, Amin MM, Khowessah OM, Tadros MI. Colon-targeted celecoxibloaded Eudragit(®) S100-coated poly-ϵ-caprolactone microparticles: preparation,
characterization and in vivo evaluation in rats. Drug Del. 2011 Sep-Oct, 18 (7): 523–
535.
4. Abd-Elbary A, Tadros MI, Alaa-Eldin AA. Development and in vitro/in vivo
evaluation of etodolac controlled porosity osmotic pump tablets. AAPS
PharmSciTech. 2011 Jun; 12(2): 485-95.
5. ElMeshad AN, Tadros MI. Transdermal delivery of an anti-cancer drug via w/o
emulsions based on alkyl polyglycosides and lecithin: design, characterization and in
vivo evaluation of the possible irritation potential in rats. AAPSPharmSciTech. 2011
Mar; 12 (1): 1-9.
6. Tadros MI. Controlled-release effervescent floating matrix tablets of ciprofloxacin
hydrochloride: Development, optimization and in vitro-in vivo evaluation in healthy
human volunteers. Eur. J. Pharm. Biopharm. 2010 Feb; 74(2): 332-339.
7. Abdelbary GA, Tadros MI. Design and in vitro/in vivo evaluation of novel nicorandil
extended release matrix tablets based on hydrophilic interpolymer complexes and a
hydrophobic waxy polymer. Eur. J. Pharm. Biopharm. 2008 Aug; 69 (3): 1018-1028.
8. Abd-Elbary A, El-laithy HM, Tadros MI. Sucrose stearate-based proniosomederived niosomes for the nebulisable delivery of cromolyn sodium. Int. J. Pharm. 2008
Jun; 357 (1- 2): 189-198.
9. Bendas ER, Tadros MI. Enhanced transdermal delivery of salbutamol sulfate via
ethosomes. AAPSPharmSciTech., 2007 Dec; 8 (4): E1-E8.
10. Elbary AA, El-laithy HM, Tadros MI. Promising ternary dry powder inhaler
formulations of cromolyn Sodium: formulation and in vitro – in vivo evaluation. Arch.
Pharm. Res. 2007 Jun; 30 (6): 785 - 792.
11. Foda NH, El-laithy HM, Tadros MI. Implantable biodegradable sponges: effect of
inter-polymer complex formation of chitosan with gelatin on the release behavior of
tramadol hydrochloride. Drug Dev. Ind. Pharm. 2007 Jan; 33(1): 7-17.
12. Foda NH, El-laithy HM, Tadros MI. Optimization of biodegradable sponges as
controlled release drug matrices: I. effect of moisture level on chitosan sponge
mechanical properties. Drug Dev. Ind. Pharm. 2004 Apr; 30(4): 369-79.
-7-
Download